scorecardresearch
Monday, September 1, 2025
TopicBharat Biotech

Topic: Bharat Biotech

After filing for Covaxin patent solo, Bharat Biotech to add ICMR as co-inventor

Hyderabad-based vaccine maker says not including ICMR in original patent application for Covaxin was ‘inadvertent error’ & ‘confidential agreement between them was not accessible’.

Several immunisation drives hit, Union govt prods Bharat Biotech over ‘delay’ in vaccine supplies

Health ministry points at shortfall in supply of 3 vaccines, for Japanese Encephalitis, Hepatitis B & rotavirus. It also sought reason for delay in letter to Bharat Biotech.

World’s 1st Covid nasal vaccine by Bharat Biotech to launch on R-Day, says founder Krishna Ella

Speaking at International Science Festival in Bhopal, Krishna Ella said iNCOVACC will be launched by 26 Jan and a vaccine for lumpy skin disease, too, will be launched next month.

Bharat Biotech’s Covid nasal vaccine to be sold for Rs 325 at govt hospitals, Rs 800 at private

The Union health ministry said that those who have previously taken Covishield and Covaxin could take the nasal vaccine as a heterologous booster dose.

Bharat Biotech’s booster nasal vaccine on CoWIN from today as India strengthens Covid response

Official sources clarifeid that masks were not mandatory yet. Congress’s Bharat Jodo Yatra can also continue provided it adhered to Covid protocols, they said.

‘Fake news’ — Bharat Biotech, govt deny report on ‘discrepancies’ in Covaxin trial data

Medical news site STAT had cited internal documents to allege that Bharat Biotech had taken ‘questionable’ steps under political pressure to speed up development of Covaxin.

Drug authority clears use of India’s first nasal Covid-19 vaccine made by Bharat Biotech

The Covaxin maker’s nasal shot will be used in emergency situations for the 18+ age group, Union Health Minister Mansukh Mandaviya tweeted.

WHO move to suspend Covaxin’s UN supply won’t affect trips to UK, US & over 90 nations, govt says

Bharat Biotech is believed to have assured Government of India that it will ‘quickly’ reply to WHO about ‘deficiencies found in its manufacturing’ during an inspection last month.

DCGI gives emergency use approval to Biological E’s Corbevax vaccine for kids aged 12-18

It is the second Covid vaccine to get approval for use in children in India after Bharat Biotech's Covaxin.

ICMR received Rs 171.74 cr in royalty from sale of Covaxin till 31 Jan, govt tells Rajya Sabha

ICMR and Bharat Biotech developed Covaxin together, and MoS Health Bharati Pawar says in written reply that the research body spent Rs 35 crore on its development.

On Camera

Essential oils aren’t just about nice smells. They can change your skincare routine

Essential oils contain powerful properties that can help address concerns like acne, aging, hydration, and inflammation.

A Rs 33,000 cr ‘banking fraud’: ED’s case against Arvind Dham, Amtek’s web of ‘500 shell companies’

ED has accused Amtek promoter Arvind Dham of controlling web of nearly 500 shell companies operating as a layered structure, with up to 15 levels of indirect ownership, to divert funds.

‘Real-time, all-climate’ explosives detector could enhance airport & border security—no dogs, no swabs

Bengaluru-based CeNS designs accurate, portable, and cheap sensor using surface-enhanced Raman spectroscopy. It could significantly reduce risks at vulnerable choke points. 

For Indian Mercedes, Asim Munir’s dumper truck in mirror is closer than it appears

From Munir’s point of view, a few bumps here and there is par for the course. He isn’t going to drive his dumper truck to its doom. He wants to use it as a weapon.